Gedeon Richter - PregLem S.A.
Jackie Opizzi has extensive experience in the pharmaceutical industry, serving as a medical delegate since January 2000. Currently, Jackie Opizzi works at Gedeon Richter - PregLem S.A. since September 2016, focusing on medical delegation. Previously, Jackie Opizzi held the same role at Pierre Fabre from February 2008 to August 2016, promoting specialties in diabetology, cardiology, pulmonology, and dermatology. Prior tenure at Bayer HealthCare from January 2000 to February 2008 involved medical visits to general practitioners, specialists, and pharmacists, with a focus on gynecology, gastroenterology, dermatology, and phytotherapy. Education includes ongoing studies at SUP SANTE PARIS for a Medical Visitor degree, alongside a License and Master's in Business Administration from Université Paris-Est Créteil, a BTS in Commercial Action from Lycée Jean Moulin à Torcy, and a Baccalauréat ES from Lycée Jehan de Chelles, Chelles.
This person is not in any offices
Gedeon Richter - PregLem S.A.
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.